Erythematous-violaceous plaque in the frontal región

Authors

  • Bruce Knudsen San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina
  • Melisa Giselle Baigorria San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina
  • Dolly Lucini San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina
  • Mara Ivanov San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina

DOI:

https://doi.org/10.47196/dpa1jk22

Keywords:

erythematoviolaceous plaque, frontal región

Abstract

A 47-year-old male patient from Peru, a gardener by trade with no significant personal or family medical history, presented with an asymptomatic dermatosis on the forehead that had been evolving for two years. Physical examination of the forehead revealed erythematous-violaceous papules coalescing into a plaque with ill-defined, irregular borders; coalescent nodules partially involved the frontal hairline (Photo 1). The patient denied any history of local trauma, medication use, or infectious diseases in the months preceding the onset of the condition. Differential diagnoses considered included subcutaneous mycosis, papular mucinosis, sporotrichosis, phymatous rosacea, atypical mycobacterial infection, and folliculotropic mycosis fungoides. A 4 mm punch biopsy was performed for histopathological analysis, revealing an unremarkable epidermis. In the dermis, mild vascular dilation was observed, associated with an increased angiocentric chronic lymphocytic inflammatory infiltrate and abundant plasma cells; consequently, a Warthin-Starry stain was performed, yielding a negative result. No granulomatous reaction or deposits of amyloid or mucoid material were evident. PAS and Grocott stains were also negative (Photo 2). Additionally, mycological and bacteriological skin studies were requested—including cultures for atypical mycobacteria and common pathogens—but showed no microbial growth. General laboratory tests and serology (HBV, HCV, HIV) were also performed, with results falling within normal ranges. Due to issues regarding treatment accessibility, second-line therapy was initiated using minocycline (100 mg/day) and 1% ivermectin cream, alongside skin care measures, photoprotection, and avoidance of triggering factors. The patient showed clinical improvement and is currently being followed by our department, with no signs of recurrence or new lesions (Photo 3).

Author Biographies

  • Bruce Knudsen, San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina

    Resident Physician, Department of Dermatology

  • Melisa Giselle Baigorria, San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina

    Medical Fellow, Dermatology Department

  • Dolly Lucini, San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina

    Staff Physician, Dermatology Department

  • Mara Ivanov, San Juan de Dios Specialized Interzonal Hospital for Acute and Chronic Conditions, La Plata, Buenos Aires Province, Argentina

    Head of Department, Department of Dermatology

References

I. Hampton PJ, Berth-Jones J, Duarte Williamson CE, Hay R, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021. Br J Dermatol. 2021;185:725-735.

II. Geng RSQ, Bourkas AN, Mufti A, Sibbald RG. Rosacea: pathogenesis and therapeutic correlates. J Cutan Med Surg. 2024;28:178-189.

III. Farshchian M, Daveluy S. Rosacea. [Internet]. Treasure Island (FL): StatPearls; 2025.

IV. Chan JL, Soliman S, Miner AG, Hughes SM, et al. Metophyma: case report and review of a rare phyma variant. Dermatol Surg. 2011;37:867-869.

V. Veraldi S, Murgia G. Treatment of Metophyma with Isotretinoin. Acta Derm Venereol. 2024;104.

VI. Zhang H, Tang K, Wang Y, Fang R, et al. Rosacea treatment: review and update. Dermatol Ther. 2021;11:13-24.

Downloads

Published

2026-07-16

Issue

Section

What is your Diagnosis?